indomethacin

Class




  • Non-steroidal anti-inflammatory (NSAID)




Indomethacin


Commonly Prescribed for


(FDA approved in bold)



  • Rheumatoid arthritis
  • Ankylosing spondylitis
  • Osteoarthritis
  • Acute painful shoulder (bursitis, tendinitis)
  • Acute gouty arthritis
  • Migraine, tension-type, and cluster headache
  • Indomethacin-responsive headache disorders: Hemicrania continua (HC)
  • Paroxysmal hemicrania, primary cough headache, primary exertional headache, preorgasmic headache, primary stabbing or “ice-pick” headache, hypnic headache
  • Suppression of uterine activity to prevent premature labor



Indomethacin


How the Drug Works



  • Like other NSAIDs, inhibits cyclo-oxygenase (predominantly cox-1) thus inhibiting synthesis of prostaglandins, a mediator of inflammation
  • The reason indomethacin is more effective than other NSAIDs for many headache disorders is unclear, but could be due to its structural similarities to serotonin, central vasoconstrictive and analgesic properties, or lowering of intracranial pressure. It also inhibits the metabolism of an active progesterone metabolite



Indomethacin


How Long Until It Works



  • Migraine: (acute) less than 2 hours
  • Indomethacin-responsive headache disorders: (preventive) less than a week after starting a given daily dose



Indomethacin


If It Works



  • Continue to use



Indomethacin


If It Doesn’t Work



  • Migraine: change to a triptan, dihydroergotamine, antiemetic or another NSAID
  • Indomethacin-responsive headache disorders: reconsider the diagnosis



Indomethacin


Best Augmenting Combos for Partial Response or Treatment-Resistance



  • Migraine: combine with triptan or antiemetic



Indomethacin


Tests



  • None required



Adverse Effects (AEs)




Indomethacin


How Drug Causes AEs



  • Effects on prostaglandins likely cause most GI and renal AEs



Indomethacin


Notable AEs



  • Dyspepsia, dizziness, nausea, diarrhea most common
  • Inhibition of platelet aggregation is usually mild
  • Elevation in hepatic transaminases (usually borderline)



Indomethacin


Life-Threatening or Dangerous AEs



  • GI ulcers and bleeding, increasing with duration of therapy
  • May worsen depression, psychiatric disturbances, and parkinsonism
  • May increase risk of fluid retention and edema, cardiovascular events, including myocardial infarction and stroke
  • Renal insufficiency, proteinuria, and hyperkalemia
  • Aseptic meningitis (rare)
  • Hypersensitivity reactions – most common in patients with asthma



Indomethacin


Weight Gain



  • Unusual



Indomethacin


Sedation



  • Not unusual



Indomethacin


What to Do About AEs



  • For significant GI or intracranial bleeding, stop drug. Some AEs respond to lowering dose

Feb 16, 2017 | Posted by in PHARMACY | Comments Off on indomethacin

Full access? Get Clinical Tree

Get Clinical Tree app for offline access